Immunosenescence Correlates with Poor Outcome from PD-(L)1 Blockade but Not Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Ferrara, R. [1 ]
Naigeon, M. [2 ]
Auclin, E. [3 ]
Duchemann, B. [2 ]
Cassard, L. [2 ]
Medhi, J. J. [2 ]
Boselli, L. [2 ]
Grivel, J. [2 ]
Desnoyer, A. [2 ]
Texier, M. [2 ]
Mezquita, L. [2 ]
Aboubakar, F. [2 ]
Hendriks, L. [4 ]
Planchard, D. [2 ]
Caramella, C. [5 ]
Remon, J. [6 ]
Ngocamus, M. [2 ]
Nicotra, C. [2 ]
Proto, C. [1 ]
Sangaletti, S. [7 ]
Chaput, N. [2 ]
Besse, B. [2 ]
机构：
[1] Fdn Irccs Ist Nazl Tumori Milan, Thorac Oncol Unit, Milan, Italy
[2] Gustave Roussy, Villejuif, France
[3] Hop Europeen Georges Pompidou, Paris, France
[4] Gustave Roussy, Oncol, Villejuif, France
[5] Gustave Roussy Canc Campus, Dept Radiol, Villejuif, France
[6] Hosp Hm Delfos, Barcelona, Spain
[7] Fdn Irccs Ist Nazl Tumori, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Immunecheckpoint blockade; immunosenescence; NSCLC;
D O I：
10.1016/j.jtho.2019.08.934
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-31
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [31] MYC expression correlates with PD-L1 expression in non-small cell lung cancer
    Kim, Eun Young
    Kim, Arum
    Kim, Se Kyu
    Chang, Yoon Soo
    LUNG CANCER, 2017, 110 : 63 - 67
  • [32] Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Zullo, L.
    Cella, E.
    Paoloni, F.
    Gualtieri, M.
    Barletta, G.
    Favero, D.
    Parisi, F.
    Dellepiane, C.
    Rossi, G.
    Bennicelli, E.
    Zinoli, L.
    Cantini, L.
    Pecci, F.
    Del Mastro, L.
    Berardi, R.
    Genova, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S78 - S79
  • [33] PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis
    Di Federico, Alessandro
    De Giglio, Andrea
    Nuvola, Giacomo
    Deiana, Chiara
    Conci, Nicole
    Gelsomino, Francesco
    Ardizzoni, Andrea
    FUTURE ONCOLOGY, 2021, 17 (32) : 4415 - 4424
  • [34] Spatial and temporal heterogeneity of PD-L1 and its impact on benefit from immune checkpoint blockade in non-small cell lung cancer (NSCLC).
    Hong, Lingzhi
    Dibaj, Seyedeh
    Negrao, Marcelo Vailati
    Reuben, Alexandre
    Roarty, Emily
    Rinsurongkawong, Waree
    Lewis, Jeff
    Gibbons, Don Lynn
    Sepesi, Boris
    Papadimitrakopoulou, Vassiliki
    Glisson, Bonnie S.
    Blumenschein, George R., Jr.
    Futreal, Phillip Andrew
    Wistuba, Ignacio Ivan
    Roth, Jack A.
    Swisher, Stephen
    Heymach, John
    Simon, George R.
    Lee, J. Jack
    Zhang, Jianjun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)
    Wei, Jia
    Moran, Teresa
    Zou, Zhengyun
    Qian, Xiaoping
    Wang, Lifeng
    Camps, Carlos
    Hu, Wenjing
    Chaib, Imane
    Sanchez, Belen
    Xu, Lixia
    Karachaliou, Niki
    Sanchez-Ronco, Maria
    Liu, Baorui
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (03) : 180 - 188
  • [36] Antioxidants as an adjunct to chemotherapy in non-small cell lung cancer (NSCLC)
    Bhutani, Manisha
    Pathak, Ashutosh K.
    Bhardwaj, Narendra
    Mohan, Anant
    Guleria, Randeep
    Kochupillai, Vinod
    ANNALS OF ONCOLOGY, 2004, 15 : 186 - 187
  • [37] Chemotherapy is Beneficial for Octogenarians with Non-Small Cell Lung Cancer (NSCLC)
    Koyi, Hirsh
    Hillerdal, Gunnar
    Kolbeck, Karl Gustav
    Brodin, Daniel
    Branden, Eva
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S895 - S895
  • [38] Association of PD-L1 expression with hotspot mutations in non-small cell lung cancer (NSCLC).
    Wan, Renping
    Zhang, Xiaoni
    Qu, Hongyue
    Li, Hui
    Li, Yingmei
    Xu, Mingyan
    Xiao, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Accelerated neoadjuvant chemotherapy of non-small cell lung cancer (NSCLC)
    Lorusso, V
    Carpagnano, F
    diRienzo, G
    Catino, A
    Cisternino, ML
    Guida, M
    Brandi, M
    Latorre, A
    Parisi, S
    Ricco, R
    deLena, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (04) : 675 - 680
  • [40] PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea
    Sun, Jong-Mu
    Zhou, Wei
    Choi, Yoon-La
    Choi, So-Jung
    Kim, Se Eun
    Wang, Zhen
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Weiner, Russell
    Park, Minjin
    Kim, Hong Kwan
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345